As tamoxifen-mediated cytotoxicity was demonstrated in ER-positive and -negative pancreatic cancer cells, whether this hormone receptor-independent inhibition effect was mediated through inhibition of PKC was then investigated. The gene discussed is PRRT2; the disease is pancreatic neoplasm.